Thursday, March 16, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

CDC Test Now Available for Emerging H7N9 Influenza

by Global Biodefense Staff
April 29, 2013

CDC Influenza A (H7N9) rRT-PCR Diagnostic AssayThe U.S. Centers for Disease Control is making available diagnostic materials to specifically detect the new avian influenza A (H7N9) virus found in China. The emerging reassortant virus has to date been confirmed in 119 humans, 22 of which have died.

On April 22, 2013, the FDA issued an Emergency Use Authorization for the CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel-Influenza A/H7 (Eurasian Lineage) Assay. While there are no known cases of H7N9 in the U.S., the authorization is a matter of putting the appropriate mechanisms in place to support public health laboratory preparedness.

In the United States, public health labs can now order the CDC H7N9 rRT-PCR reagents (primers and probes), controls and test protocol. The reagents are intended for use in conjunction with CDC’s existing test kit, the Flu rRT-PCR Dx Panel. Non public health entities can obtain primer sequences or testing protocols from the CLSIS website.

International public health agencies may also order these materials via the CDC’s Influenza Reagent Repository (IRR) website.

The CDC states that testing with the CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel-Influenza A/H7 (Eurasian Lineage) Assay should not be performed unless the patient meets clinical and epidemiologic criteria for testing suspect specimens.

For further information or assistance, an email can be sent to clsis@cdc.gov .

Source and Image Credit: Centers for Disease Control. 

Tags: Avian InfluenzaEmergency Use AuthorizationEmerging ThreatsH7N9Influenza

Related Posts

New Material Helps Train First Responders on Biothreats
Biodetection

New Material Helps Train First Responders on Biothreats

January 4, 2023
Much of the CDC is Working Remotely. That Could Make Changing the Agency Difficult.
Policy + Initiatives

Much of the CDC is Working Remotely. That Could Make Changing the Agency Difficult.

December 7, 2022
Study: Cash Incentives and Lotteries Do Little to Increase Adult Vaccinations
Medical Countermeasures

Study: Cash Incentives and Lotteries Do Little to Increase Adult Vaccinations

October 25, 2022
Researcher holds a pipette
Biodetection

These Nanotech Bubbles Burst When They Detect Viruses in the Air

October 25, 2022
Load More

Latest News

Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC